Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jul 15;98(2):358-64.
doi: 10.1172/JCI118800.

An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)

Affiliations

An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)

J A Kuivenhoven et al. J Clin Invest. .

Abstract

The first step in the splicing of an intron from nuclear precursors of mRNA results in the formation of a lariat structure. A distinct intronic nucleotide sequence, known as the branchpoint region, plays a central role in this process. We here describe a point mutation in such a sequence. Three sisters were shown to suffer from fish-eye disease (FED), a disorder which is caused by mutations in the gene coding for lecithin:cholesterol acyltransferase (LCAT). Sequencing of the LCAT gene of all three probands revealed compound heterozygosity for a missense mutation in exon 4 which is reported to underlie the FED phenotype, and a point mutation located in intron 4 (IVS4:T-22C). By performing in vitro expression of LCAT minigenes and reverse transcriptase PCR on mRNA isolated from leukocytes of the patient, this gene defect was shown to cause a null allele as the result of complete intron retention. In conclusion, we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with FED. In addition, our finding illustrates the importance of this sequence for normal human mRNA processing. Finally, this report provides a widely applicable strategy which ensures fast and effective screening for intronic defects that underlie differential gene expression.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Mol Biol. 1975 Nov 5;98(3):503-17 - PubMed
    1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
    1. Mol Cell Biol. 1984 Mar;4(3):492-9 - PubMed
    1. Nature. 1985 May 30-Jun 5;315(6018):430-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2335-9 - PubMed

Publication types

MeSH terms